We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$1.79B
AUM Growth
+$618M
Cap. Flow
+$595M
Cap. Flow %
33.32%
Top 10 Hldgs %
16.68%
Holding
4,499
New
1,230
Increased
1,153
Reduced
1,264
Closed
790

Sector Composition

Rank Sector Weight
1 Technology 13.59%
2 Financials 10.04%
3 Healthcare 8.35%
4 Industrials 7.34%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HD icon
26
Home Depot
HD
$343B
$9.63M 0.54%
+49,360
New +$9.22M
XOM icon
27
ExxonMobil
XOM
$634B
$9.57M 0.54%
115,737
+115,137
+19,190% +$9.17M
KRE icon
28
State Street SPDR S&P Regional Banking ETF
KRE
$4.55B
$9.47M 0.53%
155,218
+155,150
+228,162% +$9.73M
IWV icon
29
iShares Russell 3000 ETF
IWV
$19.5B
$9.31M 0.52%
57,397
+28,203
+97% +$4.53M
ADBE icon
30
Adobe
ADBE
$99B
$9.3M 0.52%
+38,132
New +$9.02M
WFC icon
31
Wells Fargo
WFC
$263B
$8.53M 0.48%
153,891
+153,491
+38,373% +$8.22M
IJR icon
32
iShares Core S&P Small-Cap ETF
IJR
$110B
$8.51M 0.48%
101,956
+101,877
+128,958% +$8.3M
CHTR icon
33
Charter Communications
CHTR
$16.7B
$8.43M 0.47%
28,754
+28,552
+14,135% +$8.2M
MRK icon
34
Merck
MRK
$326B
$8.25M 0.46%
142,367
+141,948
+33,878% +$8.01M
QQQ icon
35
Invesco QQQ Trust
QQQ
$445B
$8.18M 0.46%
47,645
+29,246
+159% +$4.9M
DD icon
36
DuPont de Nemours
DD
$19B
$8.04M 0.45%
48,177
+48,035
+33,827% +$8.04M
MCD icon
37
McDonald's
MCD
$194B
$7.75M 0.43%
49,448
+12,656
+34% +$2.05M
UVXY icon
38
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$237M
$7.71M 0.43%
50
+12
+32% +$2.04M
PFE icon
39
Pfizer
PFE
$144B
$7.51M 0.42%
218,322
+217,479
+25,798% +$7.43M
CVX icon
40
Chevron
CVX
$374B
$7.48M 0.42%
59,165
+52,290
+761% +$6.49M
VZ icon
41
Verizon
VZ
$201B
$7.25M 0.41%
144,075
+143,031
+13,700% +$6.92M
VWO icon
42
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$7.2M 0.4%
170,491
+34,239
+25% +$1.55M
IHI icon
43
iShares US Medical Devices ETF
IHI
$3.14B
$7.16M 0.4%
214,110
+28,560
+15% +$930K
T icon
44
AT&T
T
$169B
$7.14M 0.4%
294,476
+293,284
+24,604% +$7.36M
IBM icon
45
IBM
IBM
$214B
$6.8M 0.38%
+50,921
New +$7.1M
TVIX
46
DELISTED
VelocityShares Daily 2x VIX Short Term ETN
TVIX
$6.69M 0.37%
12,684
+9,343
+280% +$5.87M
IWB icon
47
iShares Russell 1000 ETF
IWB
$47.9B
$6.54M 0.37%
43,004
+42,104
+4,678% +$6.34M
TXN icon
48
Texas Instruments
TXN
$253B
$6.51M 0.36%
+59,095
New +$6.39M
AMGN icon
49
Amgen
AMGN
$212B
$6.48M 0.36%
+35,117
New +$6.21M
GE icon
50
GE Aerospace
GE
$377B
$6.48M 0.36%
99,311
+99,283
+354,582% +$6.62M

Similar funds

Tower Research Capital (TRC)'s Q2 2018 Portfolio in Review

As of Q2 2018, Tower Research Capital (TRC) held 4,499 positions worth $1.79B, up 53% from $1.17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Tower Research Capital (TRC) deployed $595M of net new capital in Q2 2018, opening 1,230 new positions and adding to 1,153 existing holdings. Its largest new stake was JPMorgan Chase: 180,678 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 4.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $31.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2018 buy was JPMorgan Chase: 180,678 shares worth $18.8M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2018, an estimated $51.7M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $31.8M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones REIT ETF in Q2 2018, selling an estimated $6.85M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 17% of its $1.79B portfolio in Q2 2018.
  • Tower Research Capital (TRC) opened 1,230 new positions and closed 790 in Q2 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 53% quarter-over-quarter to $1.79B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.